» Articles » PMID: 39098994

Integrating Single-cell Transcriptomics and Machine Learning to Predict Breast Cancer Prognosis: A Study Based on Natural Killer Cell-related Genes

Overview
Journal J Cell Mol Med
Date 2024 Aug 4
PMID 39098994
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer (BC) is the most commonly diagnosed cancer in women globally. Natural killer (NK) cells play a vital role in tumour immunosurveillance. This study aimed to establish a prognostic model using NK cell-related genes (NKRGs) by integrating single-cell transcriptomic data with machine learning. We identified 44 significantly expressed NKRGs involved in cytokine and T cell-related functions. Using 101 machine learning algorithms, the Lasso + RSF model showed the highest predictive accuracy with nine key NKRGs. We explored cell-to-cell communication using CellChat, assessed immune-related pathways and tumour microenvironment with gene set variation analysis and ssGSEA, and observed immune components by HE staining. Additionally, drug activity predictions identified potential therapies, and gene expression validation through immunohistochemistry and RNA-seq confirmed the clinical applicability of NKRGs. The nomogram showed high concordance between predicted and actual survival, linking higher tumour purity and risk scores to a reduced immune score. This NKRG-based model offers a novel approach for risk assessment and personalized treatment in BC, enhancing the potential of precision medicine.

Citing Articles

Identification of a Potential PGK1 Inhibitor with the Suppression of Breast Cancer Cells Using Virtual Screening and Molecular Docking.

Chen X, Zuo Z, Li X, Li Q, Zhang L Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770478 PMC: 11676932. DOI: 10.3390/ph17121636.


Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research.

Xiang L, Rao J, Yuan J, Xie T, Yan H Int J Mol Sci. 2024; 25(17).

PMID: 39273429 PMC: 11395021. DOI: 10.3390/ijms25179482.


Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis: A study based on natural killer cell-related genes.

Mao J, Liu L, Shen Q, Cen M J Cell Mol Med. 2024; 28(15):e18549.

PMID: 39098994 PMC: 11298315. DOI: 10.1111/jcmm.18549.

References
1.
Gao F, Li X, Xu K, Wang R, Guan X . c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Commun Signal. 2023; 21(1):28. PMC: 9887805. DOI: 10.1186/s12964-023-01043-1. View

2.
Myers J, Miller J . Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2020; 18(2):85-100. PMC: 8316981. DOI: 10.1038/s41571-020-0426-7. View

3.
Qiu J, Xu L, Zeng X, Wu H, Liang F, Lv Q . CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells. Front Oncol. 2022; 12:972383. PMC: 9399502. DOI: 10.3389/fonc.2022.972383. View

4.
Fujimoto Y, Inoue N, Morimoto K, Watanabe T, Hirota S, Imamura M . Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer. Cancer Sci. 2019; 111(1):209-218. PMC: 6942441. DOI: 10.1111/cas.14234. View

5.
Li C, Guan R, Li W, Wei D, Cao S, Xu C . Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis. Front Immunol. 2023; 14:1168191. PMC: 10369788. DOI: 10.3389/fimmu.2023.1168191. View